‘While molecular biomarkers such as genetics have proved valuable in the management of many diseases, the dynamic information provided by many physiological biomarkers will complement, enhance and ...

The federation of trusted research environments for genomics and health. Whilst trusted research environments are not yet ...

Gene therapies and AI – is this the next phase of genomic medicine? Increasingly, genomic testing is mainstream, but with this transformation, the focus has shifted to understand how genomics can be ...

Our policy briefings and explainers are part of our horizon-scanning programme to identify those novel technologies showing greatest promise for health research and care. Succinct and accessible, they ...

In Host genomics: lessons for infectious disease, we explore the potential of this complex field in tackling infectious disease. Based on our investigation of four major pathogens, we make ...

Bhavya Krishnan is a Policy Analyst (Biomedical Science) aspiring to bring relevant insights and innovative solutions to improve people’s health and quality of life through her work for the ...

This report outlines the case for further guidance and related support to healthcare professionals to maximise the possibility of genomic information being shared with all relevant family members.

Making science work for health, the PHG Foundation podcast, examines the most promising developments in emerging biomedical technologies, such as gene editing, polygenic scores and long-read ...

Chaitanya Erady is a policy analyst in the biomedical science division at PHG. She is passionate about exploring the potential of upcoming omics-based technologies in revolutionising the healthcare ...

Heather is a biomedical policy analyst who first developed an interest in policy when exploring the evidence base for secondary findings and associated risk estimates in individuals with and without a ...